Cucurbitacin IIb exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes.
Cucurbitacin IIb (CuIIb) is one of the major active compounds in Hemsleyadine tablets which have been used for clinical treatment of bacillary dysentery, enteritis and acute tonsilitis. However, its action mechanism has not been completely understood. This study aimed to explore the anti-inflammator...
Main Authors: | Yao Wang, Gao-Xiang Zhao, Li-Hui Xu, Kun-Peng Liu, Hao Pan, Jian He, Ji-Ye Cai, Dong-Yun Ouyang, Xian-Hui He |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089751&type=printable |
Similar Items
-
Cucurbitacin IIb alleviates colitis via regulating gut microbial composition and metabolites
by: Yinyin Zhao, et al.
Published: (2024-09-01) -
Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
by: Sreekumar Usha Devi Aiswarya, et al.
Published: (2022-06-01) -
VASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formation.
by: Yan-Ting Zhang, et al.
Published: (2014-01-01) -
Anti-Diabetic Effects of Cucurbitacins from Ibervillea lindheimeri on Induced Mouse Diabetes
by: Sonia E. Hernández Navia, et al.
Published: (2022-01-01) -
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential
by: Sreekumar Usha Devi Aiswarya, et al.
Published: (2022-08-01)